Page 28 - Akoya Biosciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Akoya Biosciences, Inc. (NASDAQ:AKYA – Get Rating) Director Matthew Winkler purchased 203,388 shares of the business’s stock in a transaction on Monday, June 12th. The shares were acquired at an average cost of $5.00 per share, with a total value of $1,016,940.00. Following the acquisition, the director now directly owns 984,513 shares in the company, […]

United statesNew yorkDekabank deutsche girozentraleAkoya biosciencesMatthew winklerPiper sandlerAsia pacificAkoya biosciences incEssex investment management coGranahan investment managementAdvisory research incMorgan stanleyAkoya biosciences company profileYork state common retirement fundGet ratingDirector matthew winkler